Literature DB >> 30988381

Outcome of αβ T cell-depleted transplantation in children with high-risk acute myeloid leukemia, grafted in remission.

Michael Maschan1, Larisa Shelikhova2, Maria Ilushina2, Zhanna Shekhovtsova2, Rimma Khismatullina2, Elena Kurnikova3, Dmitriy Pershin4, Dmitriy Balashov2, Irina Kalinina5, Yakov Muzalevskii3, Alexei Kazachenok3, Viktoria Zakharova6, Yulia Olshanskaya7, Dina Baidildina5, Dmitriy Litvinov8, Galina Novichkova5, Alexei Maschan2,5.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30988381     DOI： 10.1038/s41409-019-0531-3

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  8 in total

1.  A large-scale method for the selective depletion of alphabeta T lymphocytes from PBSC for allogeneic transplantation.

Authors:  S Chaleff; M Otto; R C Barfield; T Leimig; R Iyengar; J Martin; M Holiday; J Houston; T Geiger; V Huppert; R Handgretinger
Journal:  Cytotherapy       Date:  2007-10-04       Impact factor: 5.414

2.  Depletion of T-cell receptor alpha/beta and CD19 positive cells from apheresis products with the CliniMACS device.

Authors:  Michael Schumm; Peter Lang; Wolfgang Bethge; Christoph Faul; Tobias Feuchtinger; Matthias Pfeiffer; Wichard Vogel; Volker Huppert; Rupert Handgretinger
Journal:  Cytotherapy       Date:  2013-10       Impact factor: 5.414

Review 3.  Use of NK cell activity in cure by transplant.

Authors:  Wing Leung
Journal:  Br J Haematol       Date:  2011-08-04       Impact factor: 6.998

Review 4.  The potential role of γδ T cells after allogeneic HCT for leukemia.

Authors:  Rupert Handgretinger; Karin Schilbach
Journal:  Blood       Date:  2018-01-22       Impact factor: 22.113

5.  Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients.

Authors:  Ahmet H Elmaagacli; Nina K Steckel; Michael Koldehoff; Yael Hegerfeldt; Rudolf Trenschel; Markus Ditschkowski; Sandra Christoph; Tanja Gromke; Lambros Kordelas; Hellmut D Ottinger; Rudolf S Ross; Peter A Horn; Susanne Schnittger; Dietrich W Beelen
Journal:  Blood       Date:  2011-05-03       Impact factor: 22.113

Review 6.  New approaches to graft engineering for haploidentical bone marrow transplantation.

Authors:  Rupert Handgretinger
Journal:  Semin Oncol       Date:  2012-12       Impact factor: 4.929

Review 7.  Exploitation of natural killer cells for the treatment of acute leukemia.

Authors:  Rupert Handgretinger; Peter Lang; Maya C André
Journal:  Blood       Date:  2016-05-20       Impact factor: 22.113

8.  Unrelated donor vs HLA-haploidentical α/β T-cell- and B-cell-depleted HSCT in children with acute leukemia.

Authors:  Alice Bertaina; Marco Zecca; Barbara Buldini; Nicoletta Sacchi; Mattia Algeri; Francesco Saglio; Cesare Perotti; Anna Maria Gallina; Valentina Bertaina; Edoardo Lanino; Arcangelo Prete; Walter Barberi; Manuela Tumino; Claudio Favre; Simone Cesaro; Francesca Del Bufalo; Mimmo Ripaldi; Stella Boghen; Gabriella Casazza; Marco Rabusin; Adriana Balduzzi; Franca Fagioli; Daria Pagliara; Franco Locatelli
Journal:  Blood       Date:  2018-10-22       Impact factor: 22.113
  8 in total
  2 in total

Review 1.  Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia.

Authors:  Roberto Limongello; Andrea Marra; Antonella Mancusi; Samanta Bonato; Eni Hoxha; Loredana Ruggeri; Susanta Hui; Andrea Velardi; Antonio Pierini
Journal:  Front Immunol       Date:  2021-08-03       Impact factor: 7.561

Review 2.  T-Cell-Replete Versus ex vivo T-Cell-Depleted Haploidentical Haematopoietic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukaemia and Other Haematological Malignancies.

Authors:  Katharina Kleinschmidt; Meng Lv; Asaf Yanir; Julia Palma; Peter Lang; Matthias Eyrich
Journal:  Front Pediatr       Date:  2021-12-24       Impact factor: 3.418
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.